Last reviewed · How we verify

NCT04795765

SpineJack System Postmarket Registry

Completed Last updated 10 December 2024
What this trial tests

trial testing SpineJack system in Osteoporotic Vertebral Compression Fractures in 261 participants. Completed in 11 November 2024.

Timeline
19 August 2019
Primary endpoint
11 November 2024
11 November 2024

Quick facts

Lead sponsorStryker Instruments
StatusCompleted
Study typeOBSERVATIONAL
Enrollment261
Start date19 August 2019
Primary completion11 November 2024
Estimated completion11 November 2024
Sites12 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stryker Instruments — full company profile →

Who can join

18 and older, any sex, with Osteoporotic Vertebral Compression Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This postmarket registry is intended to prospectively collect real world data to support ongoing safety and performance of the SpineJack system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of SpineJack system

Trials testing the same drug.

Other recruiting trials for Osteoporotic Vertebral Compression Fractures

Currently open trials in the same condition.

Other Stryker Instruments trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04795765.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing